Follow
Ivan Bilic
Ivan Bilic
Department of Oncology, University Hospital Center Zagreb
Verified email at kbc-zagreb.hr
Title
Cited by
Cited by
Year
How polymorphisms of the cytochrome P450 genes affect ibuprofen and diclofenac metabolism and toxicity/Kako polimorfizmi gena citokroma P450 utječu na metabolizam i toksičnost …
V Krasniqi, A Dimovski, IK Domjanović, I Bilić, N Božina
Archives of Industrial Hygiene and Toxicology 67 (1), 1-8, 2016
582016
Pathophysiology of ischaemia-reperfusion injury
M Sirotković-Skerlev, S Plestina, I Bilić, Z Kovac
Lijecnicki vjesnik 128 (3-4), 87-95, 2006
272006
Adverse reaction to cetuximab, an epidermal growth factor receptor inhibitor
D Štulhofer Buzina, I Martinac, D Ledić Drvar, R Čeović, I Bilić, ...
Acta Dermatovenerologica Croatica 24 (1), 70-70, 2016
162016
The Most Common Cutaneous Side Effects of Epidermal Growth Factor Receptor Inhibitors and Their Management.
I Martinac, R Čeović, I Bilić, B Marinović
Acta dermatovenerologica Croatica: ADC 23 (4), 282-288, 2015
142015
DPYD polymorphisms c.496A>G, c.2194G>A and c.85T>C and risk of severe adverse drug reactions in patients treated with fluoropyrimidine‐based protocols
N Božina, I Bilić, L Ganoci, L Šimičević, S Pleština, L Lešnjaković, ...
British journal of clinical pharmacology 88 (5), 2190-2202, 2022
92022
Obesity and cancer
I Bilić
Periodicum biologorum 116 (4), 355-359, 2014
32014
Breast metastasis as the initial presentation of malignant pleural mesothelioma
L Korša, A Lukač, L Kovačević, I Bilić, M Prutki, Z Marušić
The Breast Journal 26 (10), 2063-2064, 2020
12020
Uloga polimorfizama gena dihidropirimidin-dehidrogenaze i UDP-glukuronil-transferaze u toksičnosti kemoterapije fluoropirimidinima i irinotekanom
I Bilić
University of Zagreb. School of Medicine, 2016
12016
9th Symposium and Annual Meeting of Croatian Society for Medical Oncology of Croatian Medical Association with International Participation and 11th Meeting of Oncology Pharmacy …
OP Session
Libri Oncologici: Croatian Journal of Oncology 45 (Supplement 2), I-VI, 2017
2017
PR94 tumor marker (CA 15-3) monitoring failed to detect disease relapse and triggered unnecessary procedures–report of two cases
I BiliĆ
3rd International Consensus Conference Advanced Breast Cancer, 54-54, 2015
2015
Prognostic impact of Ki-67 in Croatian women with early breast cancer (single-institution prospective observational study)
I Bilić, N Dedić Plavetić, M Kralik, P Podolski, A Koši Kunac, D Vrbanec
European Cancer Congress, S67-S67, 2013
2013
Pathophysiology: basic mechanisms of disease: tekstbook-selected chapters
I Bilić, D Dekaris, S Gamulin, Z Kovač, M Marušić, P Narancsik, Z Popović, ...
2009
Macromolecular oxidation in anisotonic suspensions of mouse spleen cells
I Bilić, Z Kovač
Cell Biochemistry and Function: Cellular biochemistry and its modulation by …, 2006
2006
Anisotonicity of cell suspension medium leads to the macromolecular oxidative alterations.
I Bilic, Z Kovac
SHOCK 23, 51-52, 2005
2005
Primjena infliksimaba u ankilozantnom spondilitisu-prva iskustva
B Anić, I Bilić, N Čikeš, M Sentić, D Bosnić, J Markeljević, M Mayer
Reumatizam 51 (2), 58-59, 2004
2004
The system can't perform the operation now. Try again later.
Articles 1–15